Short Report
Antibody persistence after Pandemic H1N1 2009 influenza vaccination among healthcare workers in Pune, India
Purchase or Subscribe
Volume 9, Issue 1 January 2013
Pages 125 - 127
http://dx.doi.org/10.4161/hv.22421
Keywords: Pandemic H1N1 2009, antibody persistence, healthcare workers, immune response, influenza vaccination, post-licensure
Authors: Babasaheb V. Tandale, Shailesh D. Pawar, Yogesh K. Gurav, Saurabh S. Parkhi and Akhilesh C. Mishra
View affiliations Hide affiliations
- Babasaheb V. Tandale
-
Corresponding author: tandale.bv@niv.co.in
National Institute of Virology; Pashan, Pune India
- Shailesh D. Pawar
-
National Institute of Virology; Pashan, Pune India
- Yogesh K. Gurav
-
National Institute of Virology; Pashan, Pune India
- Saurabh S. Parkhi
-
National Institute of Virology; Pashan, Pune India
- Akhilesh C. Mishra
-
National Institute of Virology; Pashan, Pune India
Abstract:
The healthcare workers having seroprotection at 3 weeks (n = 127) following Pandemic H1N1 2009 influenza vaccination were followed up for antibody persistence. Seroprotection at 12 mo (60.2%) was significantly lower as compared with 3 weeks (74.7%), 3 mo (77.8%) and 6 mo (75.4%). The vaccine provided seroprotection up to one year.
Received: August 9, 2012; Accepted: October 2, 2012; Published Online: October 9, 2012
Preview:
Full Text - Ahead of Print Available - Log in!